Despite evidence that essential hypertension (EH) is a state of increased oxidative stress, the data on oxidative protein modifications is lacking. Besides, the role of extracellular antioxidant enzymes in EH has not been systematically studied. Study was performed in 45 subjects with EH and 25 normotensive controls. Patients were divided into three groups according to the 2003 ESH/ESC guidelines (grade 1-3). Plasma protein reactive carbonyl derivatives (RCD) and SH-groups (as byproducts of oxidative protein damage) as well as antioxidant enzyme activities superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase were studied spectrophotometrically and correlated with blood pressure (BP). RCD levels were increased in EH patients compared to controls and correlated significantly with both systolic blood pressure (SBP) (r ¼ 0.495, Po0.01) and diastolic blood pressure (DBP) (r ¼ 0.534, Po0.01). Plasma SH-groups content was significantly lower in all patients with EH, with no correlation with BP. SOD and catalase activity in patients with grade 1 EH were similar to that of controls. Patients with grade 2 and 3 of EH had lower SOD and catalase activity. However, significant correlation with SBP and DBP was observed for catalase only (r ¼ À0.331; Po0.05 and r ¼ À0.365; Po0.05, respectively). EH patients exhibited higher plasma GPX activity compared to those in controls, and it correlated with SBP (r ¼ 0.328; Po0.05). The results presented show that increased oxidative protein damage is present in all grades of EH. In mild hypertension extracellular antioxidant enzyme activities are not decreased, suggesting they are probably not critical in early EH, but could be important in moderate to severe EH.
Introduction
Clinical studies demonstrated increased reactive oxygen species (ROS) production in various types of human hypertension including essential hypertension (EH), renovascular hypertension, malignant hypertension and preeclampsia. [1] [2] [3] [4] However, the question of whether hypertension or oxidative stress is the primary event, remains still unanswered.
The findings of increased oxidative stress in EH are based on increased levels of plasma thiobarbituric acid-reactive substances and 8-epi-isoprostanes, biomarkers of lipid peroxidation and oxidative stress in hypertensive patients. [5] [6] [7] Accumulation of ROS by-products from oxidized genomic mitochondrial DNA has also been demonstrated in individuals with EH. 6 Proteins are also among essential targets for free radical attack, both intracellular and extracellular. 8 Among potential byproducts of ROS with proteins, plasma 2,4-dinitrophenylhydrazine (DNPH) reactive carbonyl derivatives (RCD) and protein thiol groups (P-SH) have been proven as tools in monitoring oxidative protein damage in humans. 9, 10 RCD groups (aldehydes and ketones) are introduced into proteins by reactions of proteins with free radicals, while thiol groups of serum proteins, including serum albumin, have been suggested to be a 'sacrificial' antioxidant in plasma and extravascular spaces. 11 Several investigators suggested the involvement of RCD overload and enhanced thiol groups oxidation in the pathogenesis and maintenance of human renovascular hypertension. [12] [13] [14] However, no information concerning oxidative damage of proteins in patients with EH has been available. Therefore, the presence of oxidative stress-induced protein alterations in EH has yet to be addressed.
Despite much evidence which indicate that EH is a state of oxidative stress, the mechanisms contributing to increased free radical production in EH remain still elusive. During past several years it has been apparent that a major source of ROS in blood vessels is membrane-associated NADPH oxidase expressed in vasculature, the activation of which is mediated by renin-angiotensin system. 15 On the other hand, decreased activities of antioxidant enzymes (superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase) may also contribute to oxidative stress. The experimental data supporting this hypothesis are generally based on measurements of particular intracellular enzymes including red blood cells and mononuclear cells. 6, 16 Although extracellular fluids contain small amounts of antioxidant enzymes, their potential role in the occurance of oxidative stress in EH should not be underestimated. 15 Namely, the failure in the activity of antioxidant enzymes in EH might significantly influence the loss of 'vascular oxidative balance'. However, extracellular enzymatic antioxidant system has not been systematically investigated in EH patients. Therefore, it is of particular interest to test the activities of plasma antioxidant enzymes and discern its relationship with the severity of hypertension.
Since EH is a state of increased oxidative stress, we hypothesized that plasma proteins are also among essential targets for oxidative damage. We also suspected that dysregulated activity of extracellular antioxidant enzymes in EH contributes to oxidative stress in EH. In this study, oxidative protein byproducts (DNPH RCD, SH-groups) and antioxidant enzyme activities (SOD, GPX and catalase) were studied in plasma of patients with different degrees of EH. The relationship with blood pressure (BP) values was also analysed.
Materials and methods

Selection of study participants
Patients included in the study were selected from an outpatient clinic over the 1-year period of [2003] [2004] . The following were the inclusion criteria: EH defined according to the 2003 European Society of Hypertension-European Society of Cardiology (ESH/ ESC) guidelines (grade 1-3) 17 and never previously treated for hypertension or off medication for at least 1 month before the beginning of the study. In total, 45 patients were divided into three groups according to their systolic blood pressure (SBP) and diastolic blood pressure (DBP). When patient's SBP and DBP fall into different categories, the higher category was applied. 17 Patients with diabetes mellitus or cigarette smokers were excluded.
In total, 25 healthy volunteers matched in terms of age (710 years), gender and date of inclusion in the study (72 months), were selected as control group. The healthy volunteers were selected from the medical stuff. The same exclusion criteria were applied to the control group. All patients gave informed consent to enter the study and the Ethics Committee of the Hospital approved the study.
BP measurements BP was measured with a mercury sphygmomanometer, with the patient in the sitting position after 5 min of rest in a quiet environment, following the recommendations of the British Hypertension Society. SBP, DBP (Korotkoff phases I and phase V, respectively), and mean blood pressure (MBP) were averaged by using three readings measured at 5-min intervals. Differences of o5 mmHg were allowed.
Blood samples and analytical procedures
For analysis, 5 ml of peripheral venous blood was collected in tubes over trace-element free heparin in the morning, after a minimum of 8 h fasting. Plasma was separated at 3000 rpm at 41C during 15 min. The supernatant was collected and used for enzyme measurement. Determination of carbonyl and protein-thiol groups content was performed immediately after blood collection and plasma separation. Presence of haemolysis was followed by measurement of plasma haemoglobin and all patients with haemoglobin concentration 450 mg/l were excluded from the study. Biochemical profiles were measured using an autoanalyser.
Laboratory methods
Determination of RCD in plasma. The protein oxidation level was monitored by determination of 2,4-dinitrophenylhydrazine (DNPH) activity of proteins. RCD was determined by spectrophotometric method of Levine et al. 9 using DNPH as a classic carbonyl reagent.
In brief, proteins precipitated with trichloroacetic acid were suspended and incubated in a solution containing 10 mmol/l DNPH for 50 min at 371C. The resulting protein hydrazones were pelleted in a centrifuge at 11 000 g for 15 min. The pellets were washed three times with ethanol-ethyl acetate (1:1) and then once with acetone. The final precipitates (1 mg protein) were dissolved in a 1 ml buffer containing 8 M urea at 41C during 6 h. Spectrophotometric measurement of plasma RCD was performed and calculated using the extinction coefficient of DNPH-RCD at 370 nm ¼ 22 Â 10 3 /l/ mol/cm and expresses as mmol/g proteins. Protein concentration was determined by the method of Lowry et al.
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Determination of plasma thiol groups The amount of plasma thiol (P-SH) groups was determined according to the method of Jocelyn et al. 19 and expressed as mmol per gram of proteins (mmol/g prot).
Enzyme assays Cu, Zn SOD activity in the plasma was measured by the method of Misra and Fridovich, 20 based on the ability of SOD to inhibit autooxidation of epinephrine at alkaline pH (pH 10.2). One unit of SOD activity was defined as the amount of enzyme, which inhibits the oxidation of epinephrine by 50%.
Catalase activity was determined by method of Goth. 21 In this method, measurement of catalase activity is based on conversion of two molecules of hydrogen peroxide into water and oxygen. One unit of enzyme activity is defined as the amount of enzyme which catalyses hydrolysis of 1 mmol of hydrogene peroxide per minute.
GPX activity was determined by the coupled assay procedure of Gunzler et al. 22 and one unit of enzyme activity is reported as mmol NADPH oxidized/min, assuming 6.22 Â 10 3 /l/mol/cm to be the molar absorbency of NADPH at 340 nm.
Statistical analysis
For each variable, values are expressed as mean 7s.d. We calculated the intra-assay reproducibility for the oxidative stress parameters using the Bland and Altman method. 23 The coefficients of repeatability, expressed as a percentage of the nearly maximal variation, namely 4 s.d. of the measurement under investigation, ranged from 2 to 8% for SOD, GPX and catalase. The coefficients of repeatability for RCD and P-SH were 4 and 3%, respectively. Interassay variability was calculated as reproducibility from day to day for the oxidative stress parameters and expressed as the relative SD derived from the mean value. Interassay CVs ranged from 4 to 9%.
The differences between groups were sought by using ANOVA 1-way for continuous variables. Regression analysis was performed with the use of oxidative stress parameters (RCD, P-SH groups, SOD, GPX and catalase) as dependent variables and SBP or DBP as independent variables. Twotailed values of Po0.05 were considered statistically significant. Power calculation was performed by using Statistica 6.0 software, based on the mean, s.d. and sample size. For all significant tests a power of (1-b)X0.8 with ap0.05 was achieved.
Results
General characteristics and BP of the study population The study was performed in 45 hypertensive subjects and 25 control volunteers. The characteristics of the patients and control subjects are shown in Table 1 . Control subjects were normotensive and had slightly lower total cholesterol levels than did the hypertensive subjects. Among the hypertensive subjects no significant differences between groups were observed in terms of age, body mass index and biochemical profile. Table 1 summarizes data on DNPH RCD and protein thiol (P-SH) group levels in plasma of normotensive subjects and patients with different degrees of EH. RCD levels were significantly increased in all groups of EH patients compared with healthy controls. The highest level of plasma RCD was observed in subjects with EH of third grade (Table 2) . A statistically significant correlation (r ¼ 0.495, Po0.01) was observed between plasma RCD level and SBP (Figure 1a) . Plasma RCD levels also correlated significantly with DBP (r ¼ 0.534, Po0.01, Figure 1b) .
Byproducts of oxidative protein damage in plasma
Plasma protein thiol (P-SH) groups content was lower in all patients with EH compared with the normotensive subjects (Table 2 ). However, P-SH Plasma antioxidant enzyme activities SOD, GPX and catalase activities in the plasma of normotensive persons and patients with varying degrees of EH are given in Table 3 . As shown, in grade 1 hypertension, the elevated oxidative protein damage was not accompanied with decreased plasma SOD activity, a key enzyme in superoxide scavenging. However, mean SOD activity was significantly lower in hypertensive patients with grade 2 and 3 of EH when compared with normotensive subjects. SOD activity did not correlate with neither SBP (r ¼ À0.069; P40.05) nor DBP (r ¼ 0.021; P40.05). Concerning catalase activity, EH patients with grade 1 hypertension had mean enzyme activity similar to that of controls (Table 3) . However, patients with more severe hypertension (grade 2 and 3) had lower mean catalase activity compared with the enzyme activity in normotensive subjects and grade 1 EH (Table 3) . A significant correlation between plasma catalase activity and both SBP (r ¼ À0.331; Po0.05) and DBP (r ¼ À0.365; Po0.05) was observed.
Our data revealed that patients with EH had higher plasma GPX activity compared with the enzyme activity in healthy subjects, as shown in Table 3 . Mean GPX activity was two times higher in EH patients in comparison to normotensive controls. Although mean activity of GPX did not significantly differ between hypertensive groups, plasma GPX activity correlated with SBP (r ¼ 0.328; Oxidative stress in EH DV Simic et al Po0.05). However, such correlation was not found between GPX activity and DBP (r ¼ 0.186; P40.05).
Discussion
Our study has shown that patients with EH exhibit increased oxidative protein damage, based on the increased plasma RCD content and decreased levels of protein thiol groups. Oxidative modification of proteins in EH patients are accompanied by significant alterations in the extracellular SOD (ecSOD) and catalase activity, while plasma GPX activity is upregulated. Significant correlation between BP values and parameters of oxidative stress was found for plasma RCD content and catalase activity. In conditions of increased ROS formation, lipid peroxidation 3, 5, 16 and oxidative DNA damage, 6 already documented in patients with EH, it seems reasonable to assume that free radical generation in EH also leads to protein modification. The presence of free radical-initiated reactions of side chains of amino-acid residues is indicated by DNPH-reactive carbonyl groups of proteins. 8, 13, 24 In our study, significant changes in the DNPH activity of plasma proteins of EH patients have been shown for the first time. Besides, we demonstrated that the concentration of protein sulphydryl groups (P-SH) in plasma, which are important chain breaking antioxidant, 10, 11 is markedly reduced in individuals with EH. It seems unlikely that the reduction in plasma P-SH groups, as observed in our EH patients, was due to hyperproteinaemia because none of the patients suffered from hypoproteinaemia. Lower values of P-SH/P ratio calculated in all groups of EH patients support this conclusion. Thus, decreased plasma P-SH levels may be a consequence of enhanced free radicals in EH.
Until now, increased carbonyl content and/or enhanced thiol oxidation were proven only in juvenile 25 and renovascular hypertension. 14, 24, 26 Present results appear to prove the first demonstration that increased oxidative damage of plasma proteins (measured as RCD content) correlates with the BP values in EH. The consequences of such oxidative protein damage in EH and other types of hypertension may be impaired enzymatic activity and modified membrane and cellular function depending on the nature of the vulnerable protein component and the attacking radical species. 12 Thus, oxidative modifications of proteins in EH might be relevant to complications associated with EH, such as atherosclerosis and stroke.
The question arises as to whether hypertension or oxidative stress is the primary event in those processes and how the antioxidant enzymes are involved. EcSOD represents a major defense system against superoxide in vascular wall, 15 being also a target for oxidative damage. 27 EcSOD is a copper containing enzyme that is mainly produced and secreted by vascular smooth muscle cells. 15 EcSOD binds to glycosaminoglycans in the vascular extracellular matrix on the endothelial cell surface, where it dismutates superoxide and prevents inactivation of NO. 15 Although, by measuring the plasma SOD activity, in this study we estimated Grade 1 (mild) -systolic blood pressure 140-159, diastolic blood pressure 90-99 mmHg. Grade 2 (moderate) -systolic blood pressure 160-179, diastolic blood pressure 100-109 mmHg. Grade 3 (severe) -systolic blood pressure X180, diastolic blood pressure X110 mmHg. When patient's systolic and diastolic blood pressure fall into different categories, the higher category was applied.
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SOD ¼ superoxide dismutase; GPX ¼ glutathione peroxidase. SOD (U Â 10 3 /l) -one unit of enzyme activity is defined as the amount of enzyme which inhibits spontaneus oxidation of epinephrine 50% per minute. Catalase (U Â 10 3 /l) -one unit of enzyme activity is defined as the amount of enzyme which catalyses hydrolysis of 1 mmol of hydrogene peroxide per minute under specified conditions. GPX (U/l) -one unit of enzyme activity is defined as mmol NADPH oxidized/min, assuming 6.22 Â 10 3 to be the molar absorbency of NADPH at 340 nm. % ¼ compared to healthy normotensives. P ¼ compared to healthy controls; NS -no statistically significant difference compared to normotensives; Oxidative stress in EH DV Simic et al only a limited part of total vascular SOD, we believe that the lower activities observed in hypertensive patients are still representative of the situation in the vascular wall. Decreased SOD activity in plasma was also observed in Baykal et al 28 study, as well as in red blood cells 6 and mononuclear cells 16 of hypertensive patients. In addition to this decrease of intra-and extracellular detoxification of superoxide, its production in hypertension is upregulated due to an activation of NADH or NADPH oxidase that is induced by angiotensin II. 26 Thus, we suppose that in such conditions excess of superoxide anions escape antioxidant defense and contribute to decreased NO bioavailability and consequent endothelial dysfunction, already documented in EH. 29 Based on the fact that decrease in plasma SOD activity was observed only in moderate to severe hypertension, we suppose that reduction of antioxidant enzyme activity is most probably the consequence and not the cause of oxidative stress in EH.
The pattern of changes observed for plasma catalase activity in different degrees of EH resembles that of SOD. Interestingly, plasma catalase activity is decreased in a manner which parallels the severity of hypertension as measured by BP. Moreover, Lacy et al 30 reported increased plasma hydrogen peroxide levels in EH, a major catalase substrate, which also correlated significantly with BP values. 30 Although intracellular catalase is very important for detoxification of hydrogen peroxide in conditions of high hydrogen peroxide level, the role of plasma catalase activity in the degradation of extracellular hydrogen peroxide is still unclear. Besides, the precise mechanisms underlying the regulation and origin of extracellular catalase remain still unknown. The majority of plasma catalase is released from erythrocytes. 21 Since all samples with plasma Hb levels over 50 mg/l were excluded from the study, we concluded that decreased catalase activity in EH cannot be attributed to different haemolysis between samples.
In contrast to lowering of plasma SOD and catalase activities, marked increase of plasma GPX activity was found in all grades of EH. Human plasma GPX is predominantly derived from the proximal tubules of the kidneys. 31 Although the data on regulation extracellular GPX are still lacking, we suppose that upregulation of plasma GPX in EH represents probably an adaptive phenomenon to increased free radical production in all grades of hypertension. Extracellular GPX is presumed to work as part of a traditional glutathione cycle. 31 In vitro extracellular GPX reduces organic hydroperoxides, phospholipid hydroperoxides and hydrogen peroxide. 32 Studies in mice that overexpress extracellular GPX suggest a protective extracellular antioxidant activity for extracellular GPX. 33 However, the actual significance of GPX in prevention of oxidative damage in EH must be taken with some caution. In EH, despite of high GPX activity, accumulated lipid peroxyl radicals and their byproducts such as thiobarbituric acid-reactive substances and 8-epi-isoprostanes 7 as well as RCD overwhelm antioxidant capacity.
If the failure of extracellular antioxidant enzymatic system to protect plasma proteins, shown in our study, reflects the changes in the vasculature of patients with EH, molecular link between the hypertension and its complications, such as atherosclerosis and stroke becomes much more clear. Namely, in the settings of increased oxidative stress and oxidative damage of proteins, endothelial cells lose their protective phenotype and express proinflamatory molecules, which facilitate the early stages of atherosclerosis. 33 It is of note that such pro-oxidant shift could result in the activation of nuclear factor kappa B (NFkB), which triggers inflammation by promoting the transcription of proinflamatory cytokines. 34 In conclusion, the results presented provided evidence that increased oxidative protein damage is present in all grades of EH. In mild hypertension extracellular antioxidant enzyme activities are not decreased, suggesting that this line of antioxidant defense may not be critical in early stages of human hypertension, but could be important in moderate to severe EH. What this study adds Byproducts of oxidative damage a Increased lipid peroxidation in plasma, 3, 7 erythrocytes, 16 and lymphocytes 6 Increased plasma protein oxidation
Increased DNA oxidation in lymphocytes 6 Antioxidant enzyme activities Decreased superoxide dismutase activity in plasma, 28 erythrocytes 16 and lymphocytes 6 Decreased plasma superoxide activity in moderate to severe hypertension Decreased catalase activity in lymphocytes 6 and whole blood 6 Decreased plasma catalase activity in moderate to severe hypertension Decreased glutathione peroxidase activity in erythrocytes 16 and whole blood 6 Increased plasma glutahione peroxidase activity a Numbers in superscript refer to the references cited in the text of article.
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